BIO MED BI Biocytogen RenNano® by Biocytogen: Fully Human VHHs Enabling Next-Gen Antibodies, ADCs, and Cell Therapies The single VHH domain (~12–15 kDa), known for its ability to penetrate solid tumors and cross the blood-brain barrier, represents a…
GEN LIF BIO BI Biocytogen In Vivo CAR-T and HCAbs: A Powerful Duo Advancing Cancer Therapy Innovation Challenges & Innovations in CAR-T Therapy
